Literature DB >> 15507644

ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin.

William Stedman1, Zhong Deng, Fang Lu, Paul M Lieberman.   

Abstract

The viral genome of Kaposi's sarcoma-associated herpesvirus (KSHV) persists as an extrachromosomal plasmid in latently infected cells. The KSHV latency-associated nuclear antigen (LANA) stimulates plasmid maintenance and DNA replication by binding to an approximately 150-bp region within the viral terminal repeats (TR). We have used chromatin immunoprecipitation assays to demonstrate that LANA binds specifically to the replication origin sequence within the KSHV TR in latently infected cells. The latent replication origin within the TR was also bound by LANA-associated proteins CBP, double-bromodomain-containing protein 2 (BRD2), and the origin recognition complex 2 protein (ORC2) and was enriched in hyperacetylated histones H3 and H4 relative to other regions of the latent genome. Cell cycle analysis indicated that the minichromosome maintenance complex protein, MCM3, bound TR in late-G(1)/S-arrested cells, which coincided with the loss of histone H3 K4 methylation. Micrococcal nuclease studies revealed that TRs are embedded in a highly ordered nucleosome array that becomes disorganized in late G(1)/S phase. ORC binding to TR was LANA dependent when reconstituted in transfected plasmids. DNA affinity purification confirmed that LANA, CBP, BRD2, and ORC2 bound TR specifically and identified the histone acetyltransferase HBO1 (histone acetyltransferase binding to ORC1) as a potential TR binding protein. Disruption of ORC2, MCM5, and HBO1 expression by small interfering RNA reduced LANA-dependent DNA replication of TR-containing plasmids. These findings are the first demonstration that cellular replication and origin licensing factors are required for KSHV latent cycle replication. These results also suggest that the KSHV latent origin of replication is a unique chromatin environment containing histone H3 hyperacetylation within heterochromatic tandem repeats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507644      PMCID: PMC525046          DOI: 10.1128/JVI.78.22.12566-12575.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.

Authors:  Jianhong Hu; Alexander C Garber; Rolf Renne
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse.

Authors:  Hong-Guang Guo; Mariola Sadowska; William Reid; Erwin Tschachler; Gary Hayward; Marvin Reitz
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 3.  Epigenomic replication: linking epigenetics to DNA replication.

Authors:  Adrian J McNairn; David M Gilbert
Journal:  Bioessays       Date:  2003-07       Impact factor: 4.345

Review 4.  The 'ORC cycle': a novel pathway for regulating eukaryotic DNA replication.

Authors:  Melvin L DePamphilis
Journal:  Gene       Date:  2003-05-22       Impact factor: 3.688

5.  Single-molecule analysis reveals clustering and epigenetic regulation of replication origins at the yeast rDNA locus.

Authors:  Philippe Pasero; Aaron Bensimon; Etienne Schwob
Journal:  Genes Dev       Date:  2002-10-01       Impact factor: 11.361

6.  Sequence-independent DNA binding and replication initiation by the human origin recognition complex.

Authors:  Sanjay Vashee; Christin Cvetic; Wenyan Lu; Pamela Simancek; Thomas J Kelly; Johannes C Walter
Journal:  Genes Dev       Date:  2003-08-01       Impact factor: 11.361

7.  Histone acetyltransferase HBO1 interacts with the ORC1 subunit of the human initiator protein.

Authors:  M Iizuka; B Stillman
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

8.  Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency.

Authors:  Fang Lu; Jing Zhou; Andreas Wiedmer; Kevin Madden; Yan Yuan; Paul M Lieberman
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication.

Authors:  György Fejér; Maria M Medveczky; Elizabeth Horvath; Brian Lane; Yuan Chang; Peter G Medveczky
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

10.  The terminal repeats and latency-associated nuclear antigen of herpesvirus saimiri are essential for episomal persistence of the viral genome.

Authors:  Christopher M Collins; Maria M Medveczky; Troy Lund; Peter G Medveczky
Journal:  J Gen Virol       Date:  2002-09       Impact factor: 3.891

View more
  110 in total

Review 1.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

2.  A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.

Authors:  Meir Shamay; Jianyong Liu; Renfeng Li; Gangling Liao; Li Shen; Melanie Greenway; Shaohui Hu; Jian Zhu; Zhi Xie; Richard F Ambinder; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  KSHV but not MHV-68 LANA induces a strong bend upon binding to terminal repeat viral DNA.

Authors:  Rajesh Ponnusamy; Maxim V Petoukhov; Bruno Correia; Tania F Custodio; Franceline Juillard; Min Tan; Marta Pires de Miranda; Maria A Carrondo; J Pedro Simas; Kenneth M Kaye; Dmitri I Svergun; Colin E McVey
Journal:  Nucleic Acids Res       Date:  2015-09-30       Impact factor: 16.971

4.  Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins.

Authors:  Huaxin Si; Subhash C Verma; Erle S Robertson
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 5.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

6.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces a strong bend on binding to terminal repeat DNA.

Authors:  Lai-Yee Wong; Angus C Wilson
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  Functional cooperation between FACT and MCM helicase facilitates initiation of chromatin DNA replication.

Authors:  Bertrand Chin-Ming Tan; Cheng-Ting Chien; Susumu Hirose; Sheng-Chung Lee
Journal:  EMBO J       Date:  2006-08-10       Impact factor: 11.598

8.  Regulation of replication licensing by acetyltransferase Hbo1.

Authors:  Masayoshi Iizuka; Tomoko Matsui; Haruhiko Takisawa; M Mitchell Smith
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

9.  Timeless-dependent DNA replication-coupled recombination promotes Kaposi's Sarcoma-associated herpesvirus episome maintenance and terminal repeat stability.

Authors:  Jayaraju Dheekollu; Horng-Shen Chen; Kenneth M Kaye; Paul M Lieberman
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

Review 10.  Cancer stem cells and hepatocellular carcinoma.

Authors:  Zhixing Yao; Lopa Mishra
Journal:  Cancer Biol Ther       Date:  2009-09       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.